Korglutide
The first oral GLP-1 peptide for weight loss.
Korglutide
The first oral GLP-1 peptide for weight loss.
Discover Korglutide
Korglutide is an innovative oral supplement composed of a short,
highly stable peptide designed for weight management. It represents
a new era in weight loss, delivering the proven benefits of GLP-1
therapy in a convenient, non-injectable form. With clinically
demonstrated weight loss efficacy and excellent tolerability,
Korglutide is redefining the future of metabolic wellness.
Discover Korglutide
Korglutide is an innovative oral supplement composed of a short,
highly stable peptide designed for weight management. It represents
a new era in weight loss, delivering the proven benefits of GLP-1
therapy in a convenient, non-injectable form. With clinically
demonstrated weight loss efficacy and excellent tolerability,
Korglutide is redefining the future of metabolic wellness. 
Case Study 1
Week 0 (Before)
Week 16 (After)
Week 0 (Before)
Week 16 (After)
BMI (kg/m²) Week 0
36.65
BMI (kg/m²) Week 16
31.75
BMI Changes (kg)
-4.9
BMI Changes (%)
-13.37
Skeletal Muscle Mass Week 0
41.15
Skeletal Muscle Mass Week 16
39.9
Skeletal Muscle Mass Changes (kg)
-1.25
Skeletal Muscle Mass Changes (%)
-3.04
Body Fat Mass Week 0
40.2
Body Fat Mass Week 16
20.08
Body Fat Mass Changes (kg)
-12.12
Body Fat Mass Changes (%)
-30.15
Case Study 2
Week 0 (Before)
Week 16 (After)
Week 0 (Before)
Week 16 (After)
BMI (kg/m²) Week 0
35.80
BMI (kg/m²) Week 16
31.95
BMI Changes (kg)
-4.80
BMI Changes (%)
-13.41
Skeletal Muscle Mass Week 0
40.01
Skeletal Muscle Mass Week 16
39.90
Skeletal Muscle Mass Changes (kg)
-0.80
Skeletal Muscle Mass Changes (%)
-2.50
Body Fat Mass Week 0
38.70
Body Fat Mass Week 16
27.31
Body Fat Mass Changes (kg)
-10.61
Body Fat Mass Changes (%)
-28.95
The innovator behind Korglutide
Invented and developed by Caregen Co., Ltd., a global biotechnology leader in biomimetic peptide science, Korglutide embodies the company’s vision of “Innovation Without Boundaries.” Since its founding in 2001, Caregen has built a legacy of scientific excellence with over 750 global patents, 130+ international market presences, and a fully integrated R&D and manufacturing platform. Listed on the KOSDAQ and recognized as a pioneer in next-generation healthcare, Caregen continues to push the frontiers of peptide innovation, transforming science into real, life-changing health solutions.